Abstract

Hypoxia-inducible factors (HIFs) are heterodimeric transcription factors that can promote cancer growth. The development of small-molecule drugs that can inhibit the formation of the dimer is therefore a promising route to the treatment of cancer. Here, we focus on the relevant domain of the protein, the HIF2α PAS-B domain, which contains a preformed, buried cavity that binds artificial small-molecule ligands that allosterically perturb the formation of the HIF heterodimer. We examine how a representative ligand (THS-017) dissociates and re-enters the buried cavity using atomistic simulations. To enable these simulations, we applied the weighted ensemble path sampling strategy, which can generate continuous pathways with rigorous kinetics (i.e., rate constants) in orders of magnitude less computing time compared to standard simulations. Results reveal a diverse set of pathways for both the ligand unbinding and rebinding processes with estimated rate constants and methyl order parameters that are consistent with experiment.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.